Youzan Technology Limited (HKG:6051)
0.0920
-0.0110 (-10.68%)
At close: May 22, 2026
Youzan Technology Revenue
In the year 2025, Youzan Technology had annual revenue of 1.49B CNY with 3.10% growth. Youzan Technology had revenue of 773.47M in the half year ending December 31, 2025, with 6.82% growth.
Revenue
1.49B CNY
Revenue Growth
+3.10%
P/S Ratio
1.80
Revenue / Employee
887.80K CNY
Employees
1,675
Market Cap
2.99B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.49B | 44.77M | 3.10% |
| Dec 31, 2024 | 1.44B | -6.09M | -0.42% |
| Dec 31, 2023 | 1.45B | -48.60M | -3.25% |
| Dec 31, 2022 | 1.50B | -73.01M | -4.65% |
| Dec 31, 2021 | 1.57B | -250.73M | -13.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Resources Medical Holdings Company | 10.21B |
| Asia Cement (China) Holdings | 5.66B |
| Yunnan Jinxun Resources | 2.53B |
| HealthyWay | 1.74B |
| OrbusNeich Medical Group Holdings | 1.40B |
| Minieye Technology | 844.64M |
| BioDlink International Company | 831.99M |
| MicroTech Medical (Hangzhou) | 735.33M |
Youzan Technology News
- 2 months ago - Youzan Technology Earnings release: H2 2025 - Filings
- 2 months ago - Youzan Technology Slides: H2 2025 - Filings
- 10 months ago - Youzan Technology Quarterly report: H1 2025 - Filings
- 10 months ago - Youzan Technology Earnings release: H1 2025 - Filings
- 10 months ago - Youzan Technology Slides: H1 2025 - Filings